1. Home
  2. NX vs IVA Comparison

NX vs IVA Comparison

Compare NX & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$15.42

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.02

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
IVA
Founded
1927
2011
Country
United States
France
Employees
N/A
77
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
883.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NX
IVA
Price
$15.42
$4.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$28.00
$16.20
AVG Volume (30 Days)
312.5K
466.4K
Earning Date
06-04-2026
03-30-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
N/A
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$2.94
52 Week High
$22.90
$7.98

Technical Indicators

Market Signals
Indicator
NX
IVA
Relative Strength Index (RSI) 31.35 32.13
Support Level $15.57 $3.77
Resistance Level $20.81 $4.67
Average True Range (ATR) 0.82 0.32
MACD -0.12 -0.12
Stochastic Oscillator 3.21 12.35

Price Performance

Historical Comparison
NX
IVA

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: